{
  "trial_id": "NCT00564200",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patient is, in the investigator's opinion, willing and able to comply with the protocol requirements.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age over 18 and under 67 years old.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patient diagnosed with symptomatic Multiple Myeloma based on standard criteria with bad prognosis.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient who displayed a Monosomy of chromosome 13 or other adverse cytogenetic abnormality.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patient in first relapse.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient with relapsed multiple myeloma after autologous transplantation.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient has a ECOG performance status <= 2.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patient has a life-expectancy >3 months.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients who are candidates for autologous transplantation.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients must have HLA-identical sibling donors.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patient has the following laboratory values before Baseline visit: Platelet count \u2265 30000/mm3 (transfusion allowed), hemoglobin \u2265 8 g/dl (transfusion allowed) and absolute neutrophil count (ANC) \u2265 0.750/mm3.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Aspartate transaminase (AST): \u2264 2.5 x the upper limit of normal. Alanine transaminase (ALT): ): \u2264 2.5 x the upper limit of normal. Total bilirubin: \u22641.5 x the upper limit of normal. Serum creatinine value \u2264 2mg/dl",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patient present serious pathologies that make impossible chemotherapy treatments:",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Congestive heart failure, angina or heart attack during last 12 months.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Uncontrolled arterial hypertension.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Uncontrolled supraventricular arrhythmias during last 3 last months.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Ventricular arrhythmia.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Hepatic disease (Cirrhosis).",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patient has Grade 2 peripheral neuropathy within 14 days before enrollment.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patient with serious psychiatric disorders that make impossible comply satisfactorily with the protocol requirements.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "64yo woman with multiple myeloma, s/p allogeneic transplant with recurrent disease and with systemic amyloidosis (involvement of lungs, tongue, bladder, heart), on hemodialysis for ESRD who represents for malaise, weakness, and generalized body aching x 2 days. She was admitted last week with hypercalcemia and treated with pamidronate 30mg, calcitonin, and dialysis.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT00564200",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}